Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...

However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

Revenue decreased by 37.41% YoY & profit decreased by 37.47% YoY, profit at ₹133 crore and revenue at ₹474.8 crore.

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

The three-day-long 16th Asia Pharma Expo'-2025 kicked off at the Bangladesh-China Friendship Exhibition Center in Purbachal New Town today (12 February). The Bangladesh Association of Pharmaceutical ...

Universe Pharmaceuticals INC (NASDAQ:UPC), a pharmaceutical company trading at $0.19 per share, announced today a change in its proposed share consolidation ratio. The company's stock has experienced ...

MALMO, SWEDEN / ACCESS Newswire / February 12, 2025 / Ascelia Pharma (STO:ACE) today announces that the Nomination Committee in preparation for the Annual General Meeting (AGM) on 7 May 2025 has been ...

Alliance Ground International, one of the three largest North American airport logistics providers for air cargo transport, ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...